Study objective -The study aimed to determine the relative risk of being accepted for renal replacement treatment of black and Asian populations compared with whites in relation to age, sex, and underlying cause. The implications for population need for renal replacement therapy in these populations and for the development of renal services were also considered. crude relative acceptance rates compared with whites were 3 5 and 3-2 respectively. Age sex specific relative acceptance ratios increased with age in both ethnic populations and were greater in females. Age standardised acceptance ratios were increased 4-2 and 3-7 times in Asian and black people respectively. The most common underlaying cause in both these populations was diabetes; relative rates of acceptance for diabetic end-stage renal failure were 5 8 and 6 5 respectively. The European Dialysis and Transplant Association coding system was inaccurate for disaggregating non-insulin and insulin dependent forms. "Unknown causes" were an important category in Asians with a relative acceptance ofrate 5 7. The relative rates were reduced only slightly when the comparison was confined to the district health authorities with large ethnic minority populations, suggesting that geographical access was not a major factor in the high rates for ethnic minorities. Conclusion -Acceptance rates for renal replacement treatment are increased significantly in Asian and black populations. Although data inaccuracies and access factors may contribute to these findings, the main reason is probably the higher incidence of end-stage renal failure. This in turn is due to the greater prevalence of underlying diseases such as non-insulin dependent diabetes but possibly also increased susceptibility of developing nethropathy. The main implication is that these populations age demand for renal replacement treatment will increase. This will have an impact nationally but will be particularly apparent in areas with large ethnic minority populations. Future planning must take these factors into account and should include strategies for preventing chronic renal failure, especially that due to non-insulin dependent diabetes and hypertension. The data could not determine the extent to which population need was being met; further studies are required to estimate the incidence of endstage renal failue in ethnic minority populations. (J7 Epidemiol Community Health 1996;50:334-339) Although end-stage renal failure is relatively uncommon, treatment by renal replacement therapy (dialysis or transplantation) is complex, costly, and has to be given lifelong. Without treatment patients die. Provision in the UK has expanded significantly in the past decade. We present data from the national review of renal services in England, the first time a national dataset on ethnicity and uptake of health 334
black Africans, and black others were aggregated to form the denominator for black patients. Main result -Altogether 7 7% of patients accepted were Asian and 4'7% were black; crude relative acceptance rates compared with whites were 3 5 and 3-2 respectively. Age sex specific relative acceptance ratios increased with age in both ethnic populations and were greater in females. Age standardised acceptance ratios were increased 4-2 and 3-7 times in Asian and black people respectively. The most common underlaying cause in both these populations was diabetes; relative rates of acceptance for diabetic end-stage renal failure were 5 8 and 6 5 respectively. The European Dialysis and Transplant Association coding system was inaccurate for disaggregating non-insulin and insulin dependent forms. "Unknown causes" were an important category in Asians with a relative acceptance ofrate 5 7. The relative rates were reduced only slightly when the comparison was confined to the district health authorities with large ethnic minority populations, suggesting that geographical access was not a major factor in the high rates for ethnic minorities. Conclusion -Acceptance rates for renal replacement treatment are increased significantly in Asian and black populations. Although data inaccuracies and access factors may contribute to these findings, the main reason is probably the higher incidence of end-stage renal failure. This in turn is due to the greater prevalence of underlying diseases such as non-insulin dependent diabetes but possibly also increased susceptibility of developing nethropathy. The main implication is that these populations age demand for renal replacement treatment will increase. This will have an impact nationally but will be particularly apparent in areas with large ethnic minority populations. Future planning must take these factors into account and should include strategies for preventing chronic renal failure, especially that due to non-insulin dependent diabetes and hypertension. The data could not determine the extent to which population need was being met; further studies are We present data from the national review of renal services in England, the first time a national dataset on ethnicity and uptake of health Male  Female  Male  Female  Male  Female   16-54  No  1156  784  138  99  84  54  Rate  49  33  176  125  176  98  Relative rate  1 0  1-0  3-6  3-8  3-6  2-9  (95% CI) Acceptances were all those adults aged 16 and above resident in England who were accepted onto renal replacement therapy in the two years of the study. Patients who were returning to dialysis after a failed renal transplant were excluded. Average annual age and sex specific crude acceptance rates and relative risks were calculated in relation to ethnic group. Indirectly age standardised ratios were computed in relation to sex, using age (10 year bands) and sex specific rates for England as standard. Cause specific rates and relative risks were computed for each ethnic group. Data of the heterogeneous "other" ethnic group are not presented.
We estimated the geographical variation in renal replacement provision in relation to ethnic group by regional and district health authority using boundaries as at April 1991. We also investigated the possibility that acceptance rates in minority ethnic populations could be influenced by geographical access to services, since most renal units are in urban conurbations which is also where most minority ethnic populations reside. Rates for Asian and black people were therefore compared with those for whites in selected districts, namely those with the largest Asian and black populations, hence controlling for geographical access. Data for the 37 districts each with a combined Asian and black population exceeding 20 000 were pooled and acceptance rates and relative risks for ages 16 and over were derived by ethnic group and by age group.
Results
There were 5901 adult acceptances who had ethnicity coded, of which 86-3% were white people, 7-7% Asian people, and 4-7% black people. This compares with the 1991 census breakdown in England where 93-8% of the population were white, 3 0% Asian, and 1-9% black. Asian and black people aged 16 and over had threefold higher acceptance rates (3-5 and 3 2) for renal replacement therapy compared with white (table 1) . Acceptance rates increased with age in all ethnic groups in both sexes. Moreover the relative rates of black and Asian people compared with whites increased with age in both sexes especially among women. After standardising rates for age and sex relative Diabetic status was available for the whole sample. Although both types of diabetes were specified in regions other than the Thames ones, there was mis-specification, as the insulin dependent diabetes mellitus acceptance rate was increased in ethnic minorities as well as that for non-insulin dependent diabetes mellitus. There is, however, no epidemiological evidence for an increase of insulin dependent diabetes millitus in such populations. Overall, 15% of cases were diabetic. The respective figures in relation to ethnic group were 12% for white people, 21% for Asian people, and 25% for black people. Thus, diabetes was recorded as the underlying cause in almost a quarter of cases in ethnic minority groups. The relative rate for Asian people was 5 8 and that for black people was 6-5, compared with white people.
For the non-Thames regions, notable features were the increases in glomerulonephritis, pyelonephritis, and "unknown" cause in Asian people, and the higher rates of hypertension in black and Asian people (although the number of cases was small in both). In absolute terms, diabetes was the most important cause in Asian and black people, with "unknown" cause glomerulonephritis and pyelonephritis also significant in Asian people. Systemic lupus was reported in five patients, one of whom was one black, and renal tuberculosis in two, neither was Asian. Although Asian and black minority ethnic populations comprise 5% of the populaton of England, 13% of new acceptances for renal replacement therapy were from these groups. In some regions the proportions were much higher: 27% in North West Thames, 24% in North East Thames, and 19% in the West Midlands. (The Yorkshire and North Western data were incomplete due to two units being unable to provide any ethnic coding). In 18 districts over 20% of patients were Asian, and in nine over 20% were black. In total, in 19 of 178 districts over 30% of new patients were of minority ethnic origin.
We investigated the possibility that increased acceptance rates in minority ethnic populations compared with whites could reflect closer proximity to services by comparing ethnic rates with those for white people in a pooled group of 37 districts with large black and Asian populations. Whites and ethnic minority groups living in the same area would have similar geographical access, and hence, from that perspective, would be expected to have similar acceptance rates. In fact, relative rates were still high for Asian and black people compared with whites (table  4) and there was an increase in the relative rate in relation to age in both ethnic populations, although it was less marked than in England as a whole.
Discussion
This paper provides for the first time a comprehensive analysis of recent national data on the ethnic determinants of acceptance onto renal replacement therapy. We show that the "met need" for end-stage renal failure by renal replacement therapy is increased in Asian and black populations compared with whites and that the relative risks increase with age in both populations. The excess over whites is greater in minority ethnic women than in men, although in all ethnic groups male rates exceed female rates. There are specific underlying causes which contribute to these increases and in some health authorities the ethnic dimension is a major component in renal placement therapy provision.
Previous work has shown the higher, acceptance rates among Asian and black people.
Studies in the US have shown that black people have increased acceptance rates onto the Medicare funded programme compared with whites.'-0 The latest report of the US renal data for the period 1988-90 found a similar 3 9 fold increase in black acceptances, although the relative rate decreased with age.'0 The London Implementation Group reported threefold increases in crude acceptances among black and Asian people compared with whites in the four Thames regions but it did not examine data in the detail presented here.67
These data indicate met need rather than the true underlying population need, which can only be ascertained from population based surveys of the incidence of end-stage renal failure in areas with a high concentration of ethnic minority populations and consideration of the proportion in whom renal replacement therapy would be appropriate. Nevertheless, it is important to analyse why the acceptance rates are increased in Asian and black people. There are five main possibilities: * Numerator and/or denominator inaccuracies; * True increase in incidence and prevalence of underlying diseases; * Genetic or environmental susceptibility to progression to nephropathy; * Higher referral for treatment because ethnic minority populations generally live closer to renal units; * Reduced access to preventive health care that might reduce the progression of underlying diseases.
Ethnic coding was complete in over 90% of cases. As there is no evidence of selective undercoding in relation to ethnic group (the missing data were clustered in a few units with mixed local populations), uncoded cases would increase absolute rates but relative rates would remain relatively unchanged. Ethnicity was ascribed by the renal units and any inaccuracies in coding are likely to have had non-differential effects. Disease coding data were incomplete. Missing data were again clustered in a few units in areas with varying compositions of ethnic minority populations and so this again would not introduce a selective bias to the results.
Ethnic rates will be overestimated ifthere was selective underenumeration by ethnic group in the 1991 census. There is some evidence for underenumeration in young black males but the estimated magnitude is unlikely to effect the results significantly. 1 12 The underlying prevalence of some diseases known to be major causes of end-stage renal failure are increased in these populations. Studies in Britain have shown that the prevalence of non-insulin dependent diabetes mellitus among Asian people is more than four times greater than among whites."3-5 This is true of all Asian subgroups despite variation in cultural and socioeconomic factors. Twenty per cent of Asians aged 40-69 are diabetic, by 65 the proportion is a third. Mortality rates from diabetes in Asian born people in this country are three times higher than the national rate. '6 In Leicester the rate of acceptance for diabetic nephropathy was increased 10 fold among Asians compared with whites, the excess risk being confined to patients with non-insulin dependent diabetes mellitus. " Asians are also at increased risk of hypertension. In this study we showed significantly increased rates of acceptance for diabetics among Asian and a small excess of hypertension. There were also excess rates for glomerulonephritis and pyelonephritis, but very striking was the increase in "cunknown causes".
There have been three retrospective studies based on patients accepted in renal units which have compared the underlying cause by ethnic group.) '8-20 In the West Midlands Asian people had a significant excess of hypertension/renovascular disease and renal tuberculosis and a non-significant excess of "unknown" cause compared with whites. '8 In London and Leicester studies showed an excess of diabetes and unknown causes in Asians; one also found an excess of glomerulonephritis and pyelonephritis.'920 The latter study showed that unknown cause (in which patients often present late with small smooth shrunken kidneys and biopsy is not performed) was commoner in female Asians and there was an association with active non-renal tuberculosis. The authors suggest that such renal disease could be due to tubercular interstitial nephritis. We were unable to study further our cases of "unknown cause" to confirm or refute this finding and this remains a question for further research.
Black populations in the UK have a higher risk of hypertensive disease. Caribbean born people, for example, have a fivefold excess risk of mortality from hypertensive disease and a twofold excess from hypertension related diseases such as stroke.'6 They also have a markedly higher prevalence of non-insulin dependent diabetes mellitus, with mortality two to four times the national rate.'6 The US acceptance studies have shown excess in all disease categories, except polycystic kidney disease, and risk is especially increased for hypertensive end-stage renal failure,8-'0 although there is some evidence to suggest over ascertainment of this cause. Age-sex adjusted relative rates were 6-2 for hypertensive endstage renal failure and 3-8 for diabetic endstage renal failure in the latest US national data.'0 The West Midlands study found a significant excess of hypertension/renovascular disease, diabetes, and systemic lupus erythematosis in black people compared with whites,'8 and a London study noted an excess proportion of hypertensive endstage renal failure. 20 Does susceptibiity of developing nephropathy influence the incidence ofend-stage renal failure over and above the incidence of the underlying conditions? Several population based ecological studies in the US have attempted to correct the increased rates of endstage renal failure for underlying prevalence and severity of the predisposing conditions. McLellan found that hypertensive end-stage renal failure rates in black people in Georgia were still increased after adjustment for the prevalence of hypertension.2' Crude rates were increased 8-4 fold, age-sex adjusted rates 11 3, and age-sex hypertension adjusted rates 5 7, and there was no evidence that differences in blood pressure control could account for these differences.2' They postulated that increased susceptibility to end-stage renal failure or a less likely explanation, erroneous classification of hypertensive end-stage renal failure, explained the findings. There is some evidence of racial differences in the response of kidneys to hypertension,22 and another US study failed to show that the excess of hypertensive end-stage renal failure in blacks was due to prevalence, severity, or age at onset of hypertension, or to diabetes or socio-economic status.23 Similar work has been conducted to explain the excess of diabetic end-stage renal failure in black people.2425 Brancati showed that in Maryland the excess of diabetes mellitus related end-stage renal failure in black people was not explained by the higher prevalence of diabetes or hypertension or differences in age, socioeconomic status, or access to health care (defined as no regular income source or no insurance).24 The study in Leicester cited above found that the excess acceptance rate in Asians was even higher among diabetics than in the general population. 7 This suggests that Asians are more susceptible to diabetic nephropathy2627 and/or that preventive care was poorer. There is no information on the latter case in the UK.
Could excess rates be due to greater referral, as most ethnic minority populations live closer to renal units? Such supply factors are known to influence specialist services which are centralised in urban areas.28 However, the evidence of excess in different areas in the US and UK, the excess risk in 16-54 year olds who are most likely to be accepted wherever they live, and the correlation at district level between the acceptance rate and ethnic minority population found in the Thames study7 suggest this is not a major factor. In this study, the ethnic relative rates were raised even when only areas with high ethnic minority populations were studied -that is, in which the comparison white population lived within the same area. Further work is, however, required to explore in depth the relative contributions of need, access, and supply to acceptance onto renal replacement therapy. The question of whether there is reduced access to or effectiveness of preventive health care among ethnic minorities is an unexplored issue which needs further study. This might be particularly relevant to explaining the high relative rates in females in both ethnic minority groups.
These findings have several important implications for the future provision of renal services in the UK. Firstly, overall national population need in the UK will be higher than the estimate of 80 pmp.5 For example if a relative need for Asian and black people of three times that of whites is assumed, the population need is about 86 pmp for the UK as a whole based on the ethnic proportions in the 1991 census. It will be considerably higher in districts with large ethnic minority populations. However, this does not take into account the younger age structure of these populations compared to the demographically more mature white population. Relative need will increase as ethnic minority populations age, and this will be disproportionate as this study suggests that the relative risks rise with age. The caveat to this is whether younger generations of ethnic minority populations carry the same lifetime risks as the first generation. Projection of demographic trends in ethnic minorities will begin to reveal the impact of the ageing of ethnic minorities on need for renal replacement therapy.
Modelling work undertaken for the national renal review based on development of Wood's Manchester model29 estimated the steady state position of renal replacement therapy stock at which the numbers taken onto renal replacement therapy equal those dying or withdrawing. Even at current acceptance rates, the stock is projected to increase by over 50%, but at intakes approaching 90 pmp the steady state stock doubles. Preventive measures to reduce the need for renal replacement therapy in high risk populations are therefore imperative and require further development. For example, strategies for diabetes mellitus include primary prevention, secondary prevention by control of hypertension, and tertiary prevention by protein restriction and early treatment of infection.
What are the research implications? There is need for a population based estimation of the incidence of end-stage renal failure in ethnic minorities from which a true estimate of need can be derived. From this an assessment of the equity ofprovision ofrenal replacement therapy for ethnic minorities could then be made. Further studies are needed to determine whether these populations are more susceptible to kidney damage from underlying diabetes or hypertension. If increased susceptibility is found so the need for primary and secondary preventive efforts will be even more urgent. The pathogenesis of the "unknown cause" group in Asians requires elucidation.
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